Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease.

Although a trend towards a similar reduction of SPHK1 protein expression in the cortex was seen, this did not reach statistical significance (Fig. 2G ).

also in 111,027 other papers